MINI FUTURE SHORT - SARTORIUS STEDIM BIO Stock

Certificat

DE000MB55NZ2

Real-time Bid/Ask 08:32:38 2024-07-11 am EDT
16.51 EUR / 16.54 EUR -2.79% Intraday chart for MINI FUTURE SHORT - SARTORIUS STEDIM BIO
Current month-4.44%
1 month+16.52%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-11 16.73 -1.59%
24-07-10 17 -2.35%
24-07-09 17.41 +0.06%
24-07-08 17.4 +0.99%
24-07-05 17.23 -2.10%

Delayed Quote Börse Stuttgart

Last update July 11, 2024 at 08:28 am EDT

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellPUT
Underlying SARTORIUS STEDIM BIOTECH
Issuer Morgan Stanley
WKN MB55NZ
ISINDE000MB55NZ2
Date issued 2023-04-03
Strike 331.2
Maturity Unlimited
Parity 10 : 1
Emission price 4.61
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 18.42
Lowest since issue 3.95
Spread 0.03
Spread %0.18%

Company Profile

Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany.
Sector
-
More about the company

Ratings for Sartorius Stedim Biotech

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Sartorius Stedim Biotech

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
160.6 EUR
Average target price
240.6 EUR
Spread / Average Target
+49.85%
Consensus